^
    Back
    Association details:
    Biomarker:EXOC4-BRAF fusion
    Cancer:Colorectal Cancer
    Drug:Vectibix (panitumumab) (EGFR inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    Source:
    Case Rep Oncol
    Title:

    A Rare BRAF Fusion in Advanced Rectal Cancer Treated with Anti-Epidermal Growth Factor Receptor Therapy

    Published date:
    06/18/2021
    Excerpt:
    Here, we report a recurrent colorectal cancer case that harbored an EXOC4-BRAF fusion. An EXOC4-BRAF fusion was identified, and she achieved partial response to FOLFOX + panitumumab...
    Secondary therapy:
    FOLFOX
    DOI:
    10.1159/000517007